Final technical report of 'I can we can' programme

The "I Can, We Can" program, part of the Massar project (Syria), generated, analyzed and tested data to develop appropriate models for the utilization of ICT educational applications in fostering the development of qualifications towards improving employability among Syrian youth, empowering them to actively contribute to their own development, and to enable them to have a positive impact on their communities. The report summarizes projects that were implemented, research methodologies that were used to support implementation, and the evaluation process. Massar was first initiated in 2005 by the “Syria Trust Development “as a national educational and cultural program for children and adolescents

Controlled Shape and Porosity of Polymeric Colloids by Photo-Induced Phase Separation

The shape and porosity of polymeric colloids are two properties that highly influence their ability to accomplish specific tasks. For micro-sized colloids, the control of both properties was demonstrated by the photo-induced phase separation of droplets of NOA81—a thiol-ene based UV-curable adhesive—mixed with acetone, water, and polyethylene glycol. The continuous phase was perfluoromethyldecalin, which does not promote phase separation prior to UV activation. A profound influence of the polymer concentration on the particle shape was observed. As the photo-induced phase separation is triggered by UV radiation, polymerization drives the extracted solution out of the polymeric matrix. The droplets of the extracted solution coalesce until they form a dimple correlated to the polymer concentration, significantly changing the shape of the formed solid colloids. Moreover, control could be gained over the porosity by varying the UV intensity, which governs the kinetics of the reaction, without changing the chemical composition; the number of nanopores was found to increase significantly at higher intensities

Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy

Personalized cancer treatment based on specific mutations offers targeted therapy and is preferred over “standard” chemotherapy. Proteinoid polymers produced by thermal step-growth polymerization of amino acids may form nanocapsules (NCs) that encapsulate drugs overcoming miscibility problems and allowing passive targeted delivery with reduced side effects. The arginine-glycine-glutamic acid (RGD) sequence is known for its preferential attraction to αvβ3 integrin, which is highly expressed on neovascular endothelial cells that support tumor growth. Here, tumor-targeted RGD-based proteinoid NCs entrapping a synergistic combination of Palbociclib (Pal) and Alpelisib (Alp) were synthesized by self-assembly to induce the reduction of tumor cell growth in different types of cancers. The diameters of the hollow and drug encapsulating poly(RGD) NCs were 34 ± 5 and 22 ± 3 nm, respectively; thereby, their drug targeted efficiency is due to both passive and active targeting. The encapsulation yield of Pal and Alp was 70 and 90%, respectively. In vitro experiments with A549, MCF7 and HCT116 human cancer cells demonstrate a synergistic effect of Pal and Alp, controlled release and dose dependence. Preliminary results in a 3D tumor spheroid model with cells derived from patient-derived xenografts of colon cancer illustrate disassembly of spheroids, indicating that the NCs have therapeutic potential

Engineering of Doxorubicin-Encapsulating and TRAIL-Conjugated Poly(RGD) Proteinoid Nanocapsules for Drug Delivery Applications

Proteinoids are non-toxic biodegradable polymers prepared by thermal step-growth polymerization of amino acids. Here, P(RGD) proteinoids and proteinoid nanocapsules (NCs) based on D-arginine, glycine, and L-aspartic acid were synthesized and characterized for targeted tumor therapy. Doxorubicin (Dox), a chemotherapeutic drug used for treatment of a wide range of cancers, known for its adverse side effects, was encapsulated during self-assembly to form Dox/P(RGD) NCs. In addition, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), which can initiate apoptosis in most tumor cells but undergoes fast enzyme degradation, was stabilized by covalent conjugation to hollow P(RGD) NCs. The effect of polyethylene glycol (PEG) conjugation was also studied. Cytotoxicity tests on CAOV-3 ovarian cancer cells demonstrated that Dox/P(RGD) and TRAIL-P(RGD) NCs were as effective as free Dox and TRAIL with cell viability of 2% and 10%, respectively, while PEGylated NCs were less effective. Drug-bearing P(RGD) NCs offer controlled release with reduced side effects for improved therapy